Omega Fund V GP Manager, Ltd.

CIK 1641348 · last filed 2021-12-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.72M

Companies

4

Total Filings

18

Lifetime Open-Market Net

-$114.19M

Filer Profile

Reported Address
888 BOYLSTON ST., SUITE 1111
BOSTON, MA 02199
Phone
(617) 502-6538
State of Incorporation
Cayman Islands
Related Filers
Omega Fund V, L.P. — 62 joint filings, latest 2022-04-07
Omega Fund V GP, L.P. — 61 joint filings, latest 2022-04-07
Otello Stampacchia — 53 joint filings, latest 2021-05-03
Claudio Nessi — 9 joint filings, latest 2021-02-12
Anne-Mari Paster — 9 joint filings, latest 2021-02-12
Richard J. Lim — 5 joint filings, latest 2019-07-01
Omega Fund IV GP, L.P. — 3 joint filings, latest 2021-12-17
Anna Guyer Mitsak — 2 joint filings, latest 2019-05-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Nuvation Bio Inc. (NUVB.WS) Delisted 10%+ Owner 22,957,340 $0.01 $117.1K -$70.61M 2 2021-12-17
Morphic Holding, Inc. (MORF) Delisted Director 2,094,186 $56.99 $119.35M -$43.57M 12 2021-04-29
GOSS 10%+ Owner 13,506,832 $0.18 $2.37M -$19.25M 3 2019-09-23
TRVI 10%+ Owner 1,063,408 $17.26 $18.35M $19.24M 1 2019-05-13

Recent Filings · Page 2 of 2

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-01-19 Morphic Holding, Inc. (MORF) Delisted Sell (S) −94,120 -$2.87M EDGAR
2021-01-12 Morphic Holding, Inc. (MORF) Delisted Sell (S) −49,636 -$1.50M EDGAR
2021-01-08 Morphic Holding, Inc. (MORF) Delisted Sell (S) −112,660 -$3.38M EDGAR
2021-01-04 Morphic Holding, Inc. (MORF) Delisted Sell (S) −63,568 -$2.10M EDGAR
2019-09-23 GOSS Sell (S) −550,821 -$12.10M EDGAR
2019-09-18 GOSS Sell (S) −328,852 -$7.15M EDGAR
2019-05-13 TRVI Mixed +4,253,632 $19.24M EDGAR
2019-02-12 GOSS Conv (C) +27,813,664 $0 EDGAR
Showing 1118 of 18
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.